Skip to main navigation Skip to search Skip to main content

Device-detected subclinical atrial tachyarrhythmias: Definition, implications and management - An European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

  • Bulent Gorenek
  • , Jeroen Bax
  • , Giuseppe Boriani
  • , Shih Ann Chen
  • , Nikolaos Dagres
  • , Taya V. Glotzer
  • , Jeff S. Healey
  • , Carsten W. Israel
  • , Gulmira Kudaiberdieva
  • , Lars Åke Levin
  • , Gregory Y.H. Lip
  • , David Martin
  • , Ken Okumura
  • , Jesper H. Svendsen
  • , Hung Fat Tse
  • , Giovanni L. Botto
  • , Cecilia Linde
  • , Valentina Kutyifa
  • , Robert Bernat
  • , Daniel Scherr
  • Chu Pak Lau, Pedro Iturralde, Daniel P. Morin, Irina Savelieva
  • Osmangazi University
  • Leiden University
  • University of Modena and Reggio Emilia
  • National Yang Ming Chiao Tung University
  • Leipzig University
  • McMaster University
  • Epilepsy Center Bethel
  • Linköping University
  • University of Birmingham
  • Aalborg University
  • Lahey Clinic
  • Sasekai Kumamoto Hospital
  • University of Copenhagen
  • The University of Hong Kong
  • Azienda Ospedaliera Sant'Anna di Como
  • University of Basel
  • Karolinska Institutet
  • University of Rochester
  • Westpfalz-Klinikum GmbH
  • Medical University of Graz
  • Instituto Nacional de Cardiologia Ignacio Chavez
  • Ochsner Health System
  • St. George's University of London

Research output: Contribution to journal › Review article › peer-review

183 Scopus citations

Abstract

Among atrial tachyarrhythmias (AT), atrial fibrillation (AF) is the most common sustained arrhythmia. Many patients with AT have no symptoms during brief or even extended periods of the arrhythmia, making detection in patients at risk for stroke challenging. Subclinical atrial tachyarrhythmia and asymptomatic or silent atrial tachyarrhythmia often precede the development of clinical AF. Clinical AF and subclinical atrial fibrillation (SCAF) are associated with an increased risk of thromboembolism. Indeed, in many cases, SCAF is discovered only after complications such as ischaemic stroke or congestive heart failure have occurred.

Original languageEnglish
Pages (from-to)1556-1578
Number of pages23
JournalEuropace
Volume19
Issue number9
DOIs
StatePublished - 1 Sep 2017

Fingerprint

Dive into the research topics of 'Device-detected subclinical atrial tachyarrhythmias: Definition, implications and management - An European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)'. Together they form a unique fingerprint.

Cite this